13 results about "Eugenia caryophyllata" patented technology

The invention discloses a medicine for treating bedsore and application thereof.The medicine is prepared from parthenocissus tricuspidata, clove, radix aucklandiae and borneol, the parthenocissus tricuspidata serves as a monarch drug and has the effects of promoting blood circulation, removing toxins, removing blood stasis, dredging collaterals, improving local blood circulation of bedsore, promoting inflammation fading, dissolving sore and ulcer toxins and repairing damaged tissue; the clove is used as a ministerial drug to expel pus and engender tissue, inhibit wound infection and promote healing of ulcerated wounds; the radix aucklandiae is used as an adjuvant drug for promoting qi circulation, promoting blood circulation and promoting qi hyperactivity and blood circulation, and the radix aucklandiae is used as a monarch drug for removing stasis and dredging collaterals to nourish tendons and meat; borneol is used as an assistant drug, is used for resisting bacteria, relieving pain and promoting healing of non-healing after bedsore ulceration, and also can be used as a meridian guiding drug to enhance the seepage force of the drug so as to promote external transdermal absorption of the drug. Through simple composition and reasonable compatibility of the medicines, local qi and blood stasis of bedsores can be improved and wound healing can be promoted through the multi-target effect by activating blood and detoxifying, expelling pus and promoting tissue regeneration and inhibiting bacteria to control infection, so that the bedsores can be effectively treated.

The invention provides a traditional Chinese medicine composition which is prepared from bulk drugs or extracts thereof, and the bulk drugs comprise the following components in parts by weight: 200-600 parts of rhizoma bletillae, 25-75 parts of clove, 100-300 parts of cuttlebone, 25-75 parts of raw rhubarb and 25-75 parts of red halloysite. The components in the traditional Chinese medicine composition are scientifically proportioned, the synergistic effect of the medicinal materials is achieved, the symptoms of sour regurgitation and heartburn can be rapidly relieved, meanwhile, the spleen and the stomach are harmonized, and the normal function of the gastrointestinal tract is recovered. The traditional Chinese medicine composition is safe, effective and small in side effect.

The application belongs to the field of plant genetic engineering, and particularly relates to a soybean eugenol synthesis gene GmEGS and application thereof. The application provides application of a soybean eugenol synthesis protein GmEGS or a nucleic acid molecule coding the soybean eugenol synthesis protein GmEGS in increasing the content of eugenol in soybean or improving the ability of soybean to resist Phytophthora sojae, the protein GmEGS includes a protein GmEGS1a, a protein GmEGS1c and a protein GmEGS2a, the amino acid sequences of the protein GmEGS1a, the protein GmEGS1c and the protein GmEGS2a are shown in SEQ ID NO. 1-3 in sequence, and the ORF of the nucleic acid includes nucleic acid molecules shown in SEQ ID NO. 4-6. The content of eugenol in soybean can be obviously increased by transforming a soybean plant with the biomaterial of the application, and meanwhile, the disease resistance of soybean to Phytophthora sojae can also be improved. The application provides a good theoretical basis for the molecular mechanism of disease resistance of soybean, and has important significance for molecular design breeding.

The invention relates to a composition for preventing and treating plant diseases and application thereof, and belongs to the technical field of disease and pest control. The invention provides a composition for preventing and treating plant diseases. The composition is prepared from the following components in parts by mass: 5 to 15 parts of eugenol, 1 to 10 parts of fructus psoraleae extract, 2 to 8 parts of litsea cubeba extract and 6 to 12 parts of kasugamycin. According to the scheme, the components of the composition have a synergistic effect and have a remarkable bactericidal effect on various plant disease pathogenic bacteria, the prepared preparation has a good control effect on plant diseases and can control disease indexes, the dosage of the preparation is remarkably reduced compared with that of a conventional agent, and the cost of disease and pest control is greatly saved.

The present invention relates to a composition comprising delta-9-tetrahydrocannabinol (THC), alpha-bisabolol, guaiol, beta-caryophyllene and at least one terpene selected from the group consisting of linalool, alpha-humulene, nerolidol, caryophyllene oxide, alpha-pinene, camphene, beta-pinene, beta-myrcene, limonene, eucalyptol, ocimene, gamma-terpinene, terpinolene, alpha-terpinene, para-cymene, isopulegol and geraniol. The invention also relates to a pharmaceutical formulation comprising such composition. The pharmaceutical formulation according to the present invention may be used in medicine, specifically in the treatment and / or prevention of diseases associated with pain such as chronic cancer pain, somatic pain, visceral pain, central neuropathic pain, peripheral neuropathic pain or complex pain syndromes.

The invention belongs to the field of pesticides, and provides a bactericide composition for preventing and treating sorghum diseases and application of the bactericide composition, active ingredients comprise eugenol and chlorin iron, and the mass ratio of the eugenol to the chlorin iron is 1: 10-20: 1. The bactericide composition has an excellent synergistic effect on sorghum diseases; the composition can effectively reduce the usage amount of pesticides, alleviate the generation of drug resistance of diseases, alleviate environmental pollution, and is safe to crops through field observation.

The invention belongs to the field of plant genetic engineering, and particularly relates to a soybean eugenol synthesis gene GmEGS and application thereof. The invention provides application of a soybean eugenol synthetic protein GmEGS or a nucleic acid molecule encoding the soybean eugenol synthetic protein GmEGS in increasing the content of eugenol in soybeans or improving the resistance of the soybeans to phytophthora sojae. The protein GmEGS comprises a protein GmEGS1a, a protein GmEGS1c and a protein GmEGS2a, and the amino acid sequences of the protein GmEGS1a, the protein GmEGS1c and the protein GmEGS2a are sequentially shown as SEQ ID NO.1-3; the ORF of the nucleic acid comprises nucleic acid molecules as shown in SEQ ID NO. 4-6. When the biological material disclosed by the invention is used for transforming soybean plants, the content of eugenol in soybeans can be obviously increased, and meanwhile, the disease resistance of the soybeans to phytophthora sojae can also be improved. The invention provides a good theoretical basis for a soybean disease-resistant molecular mechanism, and has important significance for molecular design breeding.

The invention relates to the technical field of extraction, and in particular to a white orchid flower cell extract and a supercritical extraction method, comprising the following steps: (1) selecting white orchid flowers for standby use; (2) obtaining crushed materials; mixing the crushed materials with modified nanomaterials, and performing mixed grinding treatment; (3) drying the extractant carbon dioxide gas; (4) liquefying the carbon dioxide, and pressurizing the liquid carbon dioxide to a supercritical state; (5) obtaining a supercritical carbon dioxide fluid containing white orchid flower cell fluid; and (6) introducing the supercritical carbon dioxide fluid containing the white orchid flower cell fluid into a separation kettle, and completing extraction by decompression separation. The white orchid flower cell extract prepared by the invention is a natural product extracted from white orchid flowers and having multiple functions, and contains multiple chemical components, mainly including: linalool, 2-methylbutyric acid methyl ester, 2-methylbutyric acid, eugenol methyl ether, ethylene oxide methanol and other active ingredients.

The invention discloses a cynanchum bungei root rot pathogenic bacterium fusarium solani biological source pesticide compound composition for prevention and application of the cynanchum bungei root rot pathogenic bacterium fusarium solani biological source pesticide compound composition. The composition comprises a composition of two or more of cnidium lactone, pyrethrin and eugenol and nano drug-loading synergistic particles of the composition. Among 27 groups of pesticides compounded by three biological source pesticides according to different proportions, the cotoxicity coefficient of F.solani compounded by osthole and pyrethrin in a ratio of 2: 3 is the highest and is 139.87, the EC50 is 4.00 mg / L, and the combined toxicity shows a synergistic effect. The silicon dioxide microsphere (HMSN) loaded cnidium lactone and pyrethrin in a ratio of 2: 3 compounded agent CS-HMSN can significantly inhibit the growth of F.solani, alleviates the adverse effect of F.solani on coastal radix cynanchi bungei, and has an important application prospect.

The present invention belongs to the technical field of traditional Chinese medicine, and particularly relates to a traditional Chinese medicine composition for promoting the absorption of subchorionic hematoma in the early stage of pregnancy. The traditional Chinese medicine composition includes an oral medicine and an external patch. The external patch is prepared by grinding the following raw materials and mixing them with vinegar: Eucommia ulmoides, Boehmeria nivea root, Psoralea corylifolia, Artemisia argyi charcoal, Cassia obtusifolia, Rheum palmatum, Areca catechu, Foeniculum vulgare, Akebia quinata, Zanthoxylum bungeanum, Eugenia caryophyllata, Cinnamomum cassia, stir-fried Atractylodes macrocephala. The oral medicine is prepared by grinding the following raw materials: Cuscuta chinensis, Taxillus chinensis, Dipsacus asperoides, Colla Corii Asini, Anemarrhena asphodeloides, Phellodendron amurense, Dioscorea opposita, Paeonia lactiflora, Boehmeria nivea root, Eucommia ulmoides, Saposhnikovia divaricata, Cornus officinalis, Angelica sinensis, Rubia cordifolia, Agrimonia pilosa. The traditional Chinese medicine composition of the present invention includes an oral medicine and an external patch. The compatibility of the medicines is scientific and reasonable. The internal administration combined with external application has a significant therapeutic effect on the formation of hematoma caused by the downward aggregation of yin and blood to nourish the fetus after pregnancy, the more exuberant blood heat due to yin blood deficiency, the heat lurking in Chong and Ren meridians, the exuberant yang and blood heat, the overflow of blood due to heat, and the forced abnormal bleeding. It has the functions of stopping bleeding and preventing miscarriage.

The present invention relates to a fumigant, which is made from traditional Chinese medicine raw materials in the following weight ratios: 20 - 40 parts by weight of Astragalus membranaceus, 15 - 25 parts by weight of Paederia scandens, 10 - 20 parts by weight of Rubia cordifolia, 10 - 20 parts by weight of Cnidium monnieri, 5 - 15 parts by weight of Pueraria lobata, 5 - 15 parts by weight of Corydalis yanhusuo, 5 - 15 parts by weight of Cimicifuga foetida, 5 - 15 parts by weight of Citrus reticulata Blanco, 5 - 15 parts by weight of Vaccaria segetalis, 5 - 15 parts by weight of Eucommia ulmoides, 3 - 8 parts by weight of Eugenia caryophyllata, 3 - 8 parts by weight of Foeniculum vulgare Mill. This fumigant can be used for the treatment of pelvic floor dysfunction diseases, especially for improving stress urinary incontinence in menopausal women.

The present invention describes a composition comprising beta-caryophyllene, docosahexaenoic acid and eugenol for use as analgesic and anti-inflammatory antioxidants for the central and peripheral nervous system, administered by oral route, the compounds are useful as analgesics for chronic pain disorders, chronic inflammatory pain, chronic neuralgia and as anti-inflammatory antioxidants for the central and peripheral nervous systems.

The present invention relates to the technical field of Mongolian medicine, and discloses a Mongolian medicine named Renqing Wugete Busan for treating Heretic lung disease. This Mongolian medicine is composed of twenty-six medicinal materials including Gentiana algida Pall., Aquilaria sinensis (Lour.) Gilg, Choerospatha eriostachya (Wall.) Miq., Santalum album Linn., Myristica fragrans Houtt., Gypsum Fibrosum, Adenophora stricta Miq., Aucklandia lappa Decne., Terminalia chebula Retz., Melia toosendan Sieb. et Zucc., Gardenia jasminoides Ellis, Sophora flavescens Ait., Potentilla discolor Bunge, Dianthus superbus Linn., Eugenia caryophyllata Thunb., Glycyrrhiza glabra Linn., Vitis vinifera L., Cyperus rotundus L., Cinnamomum cassia Presl, Punica granatum L., Carthamus tinctorius L., Ilex purpurea Hassk., Alpinia oxyphylla Miq., Piper longum L., Neptunea arthritica cumingii, Bistorta officinalis Z. in specific weight part ratios. In the formula, Vitis vinifera L. and Myristica fragrans Houtt. are monarch drugs, Ilex purpurea Hassk., Carthamus tinctorius L., Gypsum Fibrosum, Glycyrrhiza glabra Linn., Adenophora stricta Miq., Cyperus rotundus L., Choerospatha eriostachya (Wall.) Miq., Santalum album Linn., Aquilaria sinensis (Lour.) Gilg are ministerial drugs, and the rest are adjuvant and guiding drugs. The total weight part ratio of the monarch drugs to the ministerial drugs is 1:3.0 - 3.4, and the total weight part ratio of the heat-clearing medicinal materials to the stomach-warming medicinal materials among the adjuvant and guiding drugs is 1:1.1 - 1.5. The present invention realizes the synchronous regulation of the disorder of Heretic and Badagan through scientific ratio, and takes into account the treatment of lung symptoms and gastrointestinal functions.